Starting January 1, 2026, the rule that forced many surgeries to be done only as "inpatient" is being rolled back.
This is a policy decision by the Centers for Medicare & Medicaid Services (CMS), not a sudden medical breakthrough. For 2026, 285 procedures (mostly musculoskeletal) were the first batch removed from the "inpatient-only" list—meaning they can now be done and reimbursed in outpatient settings.
For years, Medicare paid for certain surgeries only if they were done as inpatient. That was the "Inpatient-Only" (IPO) list. Starting in 2026, CMS began removing many procedures from that list over a 3-year phase-out.
Removing a procedure doesn't force anyone to move it. It just lets surgeons and clinics choose outpatient settings when medically appropriate. But with reimbursement barriers removed, the economics shift drastically.
Imagine a knee procedure that used to only get paid if the patient stayed overnight. Now, providers can choose the cheaper, faster outpatient site—and payers will generally prefer that because it costs less. That small rule change alters where surgeries happen at scale.
This shift creates clear winners and creates significant risk for incumbents.
First 285 codes removed. Medicare pays for these in outpatient settings immediately. Focus on musculoskeletal and spine.
3-Year Phase-Out. Additional codes come off the IPO list. ASCs gradually expand services and infrastructure.
Market Driven. The IPO list is expected to be gone. The surgical market becomes economics-driven rather than rule-driven.
If you run a hospital surgical service line or an ASC, the time to prepare is now.
To know where volume is actually moving, you need claims-level data, not just hospital schedules. Without claims, you are guessing.
Key Signals to Track: